Erweiterte Suche

Sonalee Elizabeth Parekh is currently serving as a Director at Ay Dee Kay LLC.
She is also an Independent Director at indie Semiconductor, Inc., PWP Forward Acquisition Corp.
I, and Chief Financial Officer at RingCentral, Inc. In her former positions, Ms. Parekh worked as an Executive Director at Royal Bank of Canada from 2014 to 2016.
She then served as a Managing Director-Global Capital Markets at Jefferies International Ltd.
from 2016 to 2019.
Sonalee also worked as a Research Analyst at Goldman Sachs International.
From 2019 to 2022, she held the position of CFO, SVP-Corporate Development & IR at Hewlett Packard Enterprise Co.Ms. Parekh completed her undergraduate degree at McGill University.

Salil S. Parekh ist Chief Executive Officer, MD & Executive Director bei Infosys Ltd. Herr Parekh ist auch im Vorstand von Code.org. In der Vergangenheit war er Partner bei Ernst & Young Associates LLP und Chairman-Executive Council bei Capgemini North America, Inc. Herr Parekh erhielt einen Abschluss an der Cornell University und einen Bachelor-Abschluss am Indian Institute of Technology Bombay.

Savithri Parekh bekleidet die Position des Joint Secretary & Compliance Officer bei Reliance Industries Ltd. Frau Parekh ist auch im Vorstand von Reliance Industrial Investments & Holdings Ltd. Zuvor bekleidete sie die Position der Sekretärin, Senior VP-Legal & Secretarial bei Pidilite Industries Ltd.

Vikas J.
Parekh is currently serving as the Co-Chairman at AutoStore Holdings Ltd.
He also holds director positions at Pantheon Systems, Inc., MapBox, Inc., Cohesity, Inc., and Blinkit Pvt Ltd.
In addition, he is an Independent Director at Symbotic, Inc. since 2022.
Previously, he served as the Managing Partner at SB Investment Advisers (UK) Ltd.
His former position includes being an Independent Director at WeWork, Inc. from 2022 to 2023.
Mr. Parekh completed his undergraduate and graduate studies at Georgia Institute of Technology and holds an MBA from Harvard Business School.

Deepak Shantilal Parekh ist ein indischer Geschäftsmann, der bereits an der Spitze von 12 verschiedenen Unternehmen stand. Zurzeit ist er Non-Executive Chairman der Housing Development Finance Corp. Ltd. und Non-Independent Non-Executive Chairman für HDFC Asset Management Co. Ltd. (eine Tochtergesellschaft der Housing Development Finance Corp. Ltd.), Non-Executive Chairman für die HDFC ERGO General Insurance Co. Ltd, nicht-geschäftsführender Vorsitzender der HDFC Life Insurance Co. Ltd, Non-Executive Chairman bei Glaxo India Ltd, Non-Executive Chairman bei Burroughs Wellcome (India) Ltd, Non-Executive Chairman bei Siemens Ltd und Non-Executive Chairman bei BAE Systems India (Services) Pvt Ltd. Herr Parekh ist außerdem Vorsitzender der H T Parekh Foundation, Mitglied des Institute of Chartered Accountants in England & Wales, Mitglied des INSEAD, Mitglied des Institute of Chartered Accountants of India, Mitglied der Deutsch-Indischen Handelskammer, Mitglied der Indo-Amerikanischen Handelskammer, Mitglied der Asia Society und Mitglied des Euroindia Centre und im Vorstand von 13 weiteren Unternehmen. In der Vergangenheit war er Non-Executive Chairman bei IDFC Ltd, Non-Executive Chairman für GlaxoSmithKline Pharmaceuticals Ltd. und Chairman von IDFC Private Equity Co. Ltd. Herr Parekh erwarb einen Bachelor-Abschluss am Sydenham College of Commerce & Economics.

Gegenwärtig ist Madhukar Balvantray Parekh Chairman & Managing Director bei Vinyl Chemicals (India) Ltd. und Executive Chairman für Pidilite Industries Ltd. Außerdem ist er im Vorstand von Excel Industries Ltd. und Kalva Marketing & Services Ltd. sowie von Fevicol Co, Ltd. Herr Parekh hat einen Hochschulabschluss der Universität von Wisconsin.

Dr. Raj B. Parekh ist unabhängiges Mitglied des Verwaltungsrats von Eloxx Pharmaceuticals, Inc. und General Partner von Advent Life Sciences LLP, Vorsitzender von Galapagos NV und Professor an der University of Oxford. Er ist Mitglied des Verwaltungsrats von Eloxx Pharmaceuticals, Inc, Arrakis Therapeutics, Inc, Capella Bioscience Ltd, Advent LS Services Ltd, Aleta Biotherapeutics, Inc, Aleta, Inc, Alpha Anomeric SA, Alpha Anomeric SAS, Amphista Therapeutics Ltd, Arrakis, Inc, Artax, Inc, Aura Biosciences, Inc, Aura, Inc, Cellnovo Ltd, Itara Ltd, Levicept Ltd, Performance Electronics Ltd, Project Paradise Ltd, Rappta Therapeutics Oy, Tridek-One Therapeutics SAS, Zikani Therapeutics, Inc, Novartis Venture Fund und Biocartis SA. Dr. Parekh war zuvor als General Partner bei Advent Venture Partners LLP, als Non-Executive Chairman bei Chroma Therapeutics Ltd., als CEO, Chief Scientific Officer & Senior VP-Research bei Oxford GlycoSciences Plc, als Director-Supervisory Board bei 4-Antibody AG, als Non-Executive Director bei Biocartis Group NV, als Chief Executive Officer & Director bei Biocartis SA, als Chairman bei CoCo Therapeutics Ltd, ein Non-Executive Director bei EUSA Pharma, Inc. ein Non-Executive Director bei F2G Ltd. und ein Non-Executive Director bei Jazz Pharmaceuticals UK Ltd. Darüber hinaus war er Vorstandsmitglied bei Cellnovo Group SA, AVANT Immunotherapeutics, Inc. und Celldex Therapeutics, Inc. sowie bei Celldex Research Corp. und Amsterdam Molecular Therapeutics (AMT) Holding NV, Artax Biopharma, Inc. und Avant! Corp. (Kalifornien), Avila Therapeutics, Inc, Biocartis NV, Luxfold S.A., NeRRe Therapeutics Ltd. und Thiakis Ltd. Er erhielt seinen Bachelor-Abschluss von der University of Oxford, einen Graduierten-Abschluss von der University of Oxford und einen Doktortitel von der University of Oxford.

Narendrakumar Kalyan Parekh ist Mitglied des Vorstands von Pidilite Industries Ltd. (ehemaliger Joint Managing Director & Executive Director) und 10 weiteren Unternehmen.

Der Gründer von Nilkamal Ltd., Sharad Vrajlal Parekh, ist derzeit Joint Managing Director & Executive Director bei diesem Unternehmen. In der Vergangenheit hatte er die Position des Geschäftsführers bei Maruti Suzuki India Ltd. inne. Er erhielt einen Bachelor-Abschluss von der Universität von Mumbai.

Ajay Balvantray Parekh ist im Aufsichtsrat von Pidilite Industries Ltd. und 14 weiteren Unternehmen.

Zurzeit hat Nitin Dalsukhrai Parekh die Position des Chief Financial Officer bei Cadila Healthcare Ltd. inne.

Sanket is the Founder & Managing Partner of Secocha Ventures, which he established in 2013.
Prior to that, Sanket held multiple roles at Pidilite Industries, in sales, marketing, operations, supply chain, corporate strategy & M&A over a span of 10 years.
This, combined with his personal interests in technology, shaped Secocha's investment thesis.
In addition to his role at Secocha Ventures, Sanket continues to stay involved at Pidilite, heading their Corporate VC arm which aim to find & invest in innovative startups in the company's focus areas.
Sanket holds a Bachelor’s Degree in Commerce from the University of Mumbai, an M.S.
in Marketing from Bentley College, and an MBA in Global Management from Babson College.

Sonalee Panda worked as a Chief Marketing Officer at ING Vysya Bank Ltd.

Sohail M.
Parekh is the founder who founded Syndeo Corp.
in 1999.
He held the title of Vice President-Engineering from 1999 to 2003.
Mr. Parekh's former jobs include Senior Manager-Development at Cisco Systems, Inc. in 2000, Principal at Precision Systems, Inc., Vice President-Engineering at Autonomic Networks, Inc. from 2003 to 2007, Executive Vice President-Engineering at Infoblox, Inc. from 2010 to 2016, Principal at Junction, Inc., Senior Vice President-Engineering at MobileIron, Inc. from 2018 to 2020, and Executive Vice President-Engineering at CloudPassage, Inc. from 2016 to 2018.
Mr. Parekh received an undergraduate degree from the University of Houston.

Mr. Kalpesh Parekh was previously employed as a Sales Associate by Prabhudas Lilladher Pvt Ltd., a Senior Institutional Sales by Emkay Global Financial Services Ltd.
(Broker), and a Sales Associate by JM Financial Institutional Securities Ltd.

Keyur Parekh worked as a Managing Director at Goldman Sachs International from 2010 to 2023.
He also worked as an Associate Analyst at UBS Securities LLC.

Ms. Grishma Parekh is a Managing Director at The Carlyle Group LP/Global Market Strategies/ and the Head of Carlyle Mezzanine Partners.
Prior to joining Carlyle Group in 2007, she was an investment banker with J.P.
Morgan Securities in New York.
Ms. Parekh received a Bachelor of Science in business administration with concentrations in finance information systems from the Stern School of Business at New York University.

Mr. Parekh joined Palladium in 2003.
Previously, Mr. Parekh held a senior auditing and accounting position with Motorola.
Before this, he was a senior level auditor and interned in the mergers and acquisitions transaction support group with Ernst & Young LLP.
Mr. Parekh is a CPA and earned a B.S.
in Finance and Accounting from the Stern School at New York University.

David E.
Parekh is currently the Chief Executive Officer at SRI International and a Director at the Connecticut Technology Council.
He also holds the position of Director at the United Technologies Research Center, Inc. and is a Member of the Connecticut Academy of Science & Engineering.
Previously, he served as the Deputy Director at the Georgia Tech Research Institute, Inc. and as a Principal at The Boeing Co. Parekh completed his graduate and doctorate degrees at Stanford University and obtained his undergraduate degree from Virginia Polytechnic Institute & State University.

Prateek Parekh is currently working as an Equity Strategist at Nuvama Wealth Management Ltd.
He started this job in 2012 and is still employed there.
Previously, he worked as a Strategist at JPMorgan India Pvt Ltd.

Alpa M.
Parekh was an Independent Non-Executive Director at Veritas (India) Ltd.

Greg Parekh, PhD Founder & Managing Partner Greg Parekh is the founder and a Managing Partner of New Rhein.
Before launching New Rhein, Greg led the integration planning for Alcon on behalf of Novartis AG, where he previously ran the Mergers & Acquisitions group from 2004 to 2009.
During his time at Novartis, Greg helped execute over 20 transactions with a total deal value of more than $70 billion.
Prior to joining Novartis, Greg headed Deutsche Bank’s European Healthcare Group from 1998 to 2004.
Greg joined Deutsche Bank from Bear Stearns in New York, where he started his career in 1995 as an associate in the Life Sciences group.
Greg has served as a director of the companies in which New Rhein made it initial deal-by-deal investments, Novagali Pharma, SA (a Paris, France based ophthalmology company), Chase Pharmaceuticals, a U.S.
Alzheimer’s drug company, and Biocartis NV, a Belgian oncology diagnostics company, for which Greg also served as Chief Executive Officer from 2011 to 2013.
Greg presently serves on the boards of Fund 18 portfolio companies, Softhale NV and Neuraptive Therapeutics, Inc., Butterfly Medical Ltd.
and is a director of Cancerlinq, a big-data digital healthcare platform and wholly owned subsidiary of the American Society of Clinical Oncology (ASCO).
Greg holds a Ph.D.
in Economics from Northwestern University, an executive leadership program certificate from Harvard Business School and a dual-major B.A.
from University of Rochester (magna cum laude).
Greg's hobbies include gourmet cooking, downhill skiing and music.

Neel Parekh worked as a Senior Associate at Kayne Anderson Capital Advisors LP from 2013 to 2015.
Prior to that, he worked as a Principal at UBS Financial Services, Inc. in 2010.
Mr. Parekh completed his undergraduate degree at the University of California San Diego.

Deepak K.
Parekh, also known as Deepak Parekh, worked as an Independent Non-Executive Director at Flawless Diamond (India) Ltd.

Ms. Monica A.
Parekh is Vice President & Analyst at HSBC Securities USA, Inc. Prior to joining HSBC Securities in August 2008, Ms. Parekh was employed as Vice President & Portfolio Analyst by Lazard Asset Management LLC and a Research Analyst by JPMorgan Securities, Inc. She was also employed by American Express.
Ms. Parekh received a BA degree, major in Biochemistry, minor in Economics from Rutgers-The State University of New Jersey in New Brunswick and an MBA in Finance and Accounting from the University of Chicago-Booth School of Business.

Jayesh Parekh was the founder of MobiApps Holdings Pte Ltd.
(founded in 2000) and Good Startup Pte Ltd.
(founded in 2020) where he holds the titles of Director and Managing Partner respectively.
Mr. Parekh is also the founder of ProPoor, Sony Entertainment Television India Ltd.
Mr. Parekh currently holds multiple director positions at eBus India, Apollo Television GmbH, Milaap Social Ventures India Pvt Ltd., One Animation Pte Ltd., Apollo Televisions Pte Ltd., Flickbay Pvt Ltd., Sanctum Wealth Management Pvt Ltd., and also serves as an Advisor at Aavishkaar Inc. He is an Entrepreneur-in-Residence at INSEAD and a Member of The Indus Entrepreneurs.
Additionally, Mr. Parekh is a Trustee at TiE Mumbai.
In the past, Mr. Parekh held director positions at United Way Worldwide and iSyndica USA, Inc. He also served as an Independent Non-Executive Director at Shemaroo Entertainment Ltd.
from 2011 to 2015.
Mr. Parekh worked as a Principal at International Business Machines Corp.
and as a Managing Partner at Jungle Ventures Pte Ltd.
He was also a Special Advisor at Vistas Media Acquisition Co., Inc.Mr. Parekh completed his graduate degree at The University of Texas at Austin and his undergraduate degree at the University of Baroda.

Urvashi D.
Parekh is Finance Director of Jamies Bars Plc.

Mr. Rishi Parekh is a Managing Director at JPMorgan Securities LLC.
Mr. Parekh was previously employed as a Research Analyst by Barclays Capital, Inc., Sterne, Agee & Leach, Inc., and KBC Securities USA, Inc.

Neerav Parekh founded Net4Nuts Ltd.
in 1999, where he worked as Senior Vice President-Operations from 1999 to 2009.
Mr. Parekh received his graduate degree from Stanford University.

Archana Parekh is currently a Director at both 100 Women In Hedge Funds and 100 Women In Finance Foundation.
Previously, she worked as an Investment Director at Temasek Holdings Pte Ltd.
and as a Portfolio Manager at SeaTown Holdings International Pte.
Ltd.
from 2011 to 2019.

Rulan S.
Parekh is an Independent Director at the Conference of Independent Schools of Ontario and an Associate Professor at the University of Toronto.
Previously, Parekh served as a Trustee at the American Kidney Fund, Inc.

Mr. Ruchir Parekh is Senior Vice President & Fund Manager at HSBC Asset Management (India) Pvt Ltd.
He has over 10 years of experience in research and fixed income management.
Mr.Parekh joined HSBC from AIG Global Asset Management (India) Pvt.
Ltd.
on January 2011.
He was also Senior Manager, Fixed Income Analyst at Bear Stearns & Co., New York, NY and Senior Associate at Moody's Investors Service, New York, NY.

Anil K.
Parekh has a current job in psychiatry at Somerset Hospital.

Sweta Parekh is a Member of the Institute of Company Secretaries of India.
She worked as a Secretary & Compliance Officer at Patel Integrated Logistics Ltd.
from 2020 to 2022.
Currently, she holds a position at the Institute of Company Secretaries of India.

Nayant Parekh currently works at Morgan Stanley India Co. Pvt Ltd., as Equity Strategist from 2020.

Amit Parekh currently works as an Associate at CBRE, Inc.

Selene G.
Parekh is currently the Director at American Orthopaedic Foot & Ankle Society since 2013.
Additionally, Dr. Parekh is an Advisor at Excelerate Health Ventures LLC.
Dr. Parekh received a doctorate degree from Boston University in 1999.

Jay Parekh worked as a Principal & Vice President at Blackstone Corporate Private Equity from 2008 to 2018.
Prior to that, he obtained an undergraduate degree from New York University.

Girishkumar Natverlal Parekh currently works at Glilot Capital Investments GP Ltd., as Advisor and CompTIA UK Ltd., as Advisory Board Member.
Mr. Parekh also formerly worked at Cisco International Ltd., as Director, Splunk, Inc., as Chief Product & Infrastructure Security Officer from 2018 to 2021, Five9, Inc., as Chief Information Security Officer, and Axonius, Inc., as Member Of The Board Of Advisor from 2018 to 2022.
Mr. Parekh received his graduate degree from the University of Florida.

Nitinkumar Dalsukhray Parekh currently works at Zydus Animal Health Ltd., as Director.

Purvesh Parekh has worked as the Head of Investor Relations at Infibeam Avenues Ltd.
since 2017.